FierceBiotech 1 déc. 2025 Akebia to pay $12M to Q32 Bio for centerpiece of rare kidney disease pipeline
FierceBiotech 1 déc. 2025 Protego plans pivotal trial for AL amyloidosis prospect with $130M series B
FierceBiotech 1 déc. 2025 Meeting patients where they are: tailored support to drive recruitment and retention
FierceBiotech 26 nov. 2025 Vaccine-focused Valneva consolidates R&D footprint by shuttering site, eliminating 30 roles
FierceBiotech 26 nov. 2025 Lawmakers probe FDA's new priority voucher program, cite corruption and rushed review concerns
FierceBiotech 26 nov. 2025 US commission recommends federal research revamp to avoid losing global biotech edge
FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/biotech/pfizer-details-phase-3-data-mrna-flu-vaccine" hreflang="en">Pfizer's mRNA flu vaccine shows 34.5% greater efficacy than standard shot in phase 3</a> #mRNA flu #Pfizer mRNA
FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/providers/cdc-updates-autism-claims-website" hreflang="en">CDC updates website to say vaccines may cause autism without new evidence</a> #CDC updates #updates website
FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/medtech/cooper-companies-under-activist-pressure-split-different-ways" hreflang="en">The Cooper Companies under activist pressure to split—in different ways</a> #Cooper Companies #past month
FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/biotech/modernas-reshaping-rolls-3-more-pipeline-purges" hreflang="en">Moderna's reshaping rolls on with 3 more pipeline purges</a> #Moderna reshaping #vaccine Spikevax